238 related articles for article (PubMed ID: 12321968)
1. The political challenges and educational opportunities around very early abortion.
Saul R
Guttmacher Rep Public Policy; 1999 Feb; 2(1):5-7. PubMed ID: 12321968
[TBL] [Abstract][Full Text] [Related]
2. Congress delves into science with RU-486.
Kaeser L
Contracept Technol Update; 1998 Dec; 19(12):161-3. PubMed ID: 12321809
[TBL] [Abstract][Full Text] [Related]
3. Mifepristone approval delayed, supporters look to action by FDA.
Contracept Technol Update; 2000 May; 21(5):53-5. PubMed ID: 12295903
[TBL] [Abstract][Full Text] [Related]
4. Scientists change the face of debate with RU-486 decision. Abortion issues.
Sex Wkly Plus; 1996; (Sample No):7-8. PubMed ID: 12320371
[TBL] [Abstract][Full Text] [Related]
5. [Population Council responsible for RU486 clinical trials in USA].
Aguillaume CJ
Ref Gynecol Obstet; 1993 Apr; 1(4):392. PubMed ID: 12288154
[TBL] [Abstract][Full Text] [Related]
6. Suggested FDA restrictions might curtail access to mifepristone.
Contracept Technol Update; 2000 Aug; 21(8):89-91. PubMed ID: 12349758
[TBL] [Abstract][Full Text] [Related]
7. Medical abortion options may advance in 1998.
Contracept Technol Update; 1997 Dec; 18(12):149-50. PubMed ID: 12348221
[TBL] [Abstract][Full Text] [Related]
8. Clinton repeals antiabortion policies as activists map out new strategies.
Wash Memo Alan Guttmacher Inst; 1993 Feb; (3):1-2. PubMed ID: 12286087
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive research: still inadequate after all these years?
Diconsiglio JM
Family Plan World; 1992; 2(6):14. PubMed ID: 12344623
[TBL] [Abstract][Full Text] [Related]
10. Foundation gets rights to RU-486. "Abortion pill" stalled in U.S.
Sun; 1994 May; ():1A, 9A. PubMed ID: 12287701
[TBL] [Abstract][Full Text] [Related]
11. Introduction of RU 486 in the USA: obstacles and opportunities.
Thoss E
Plan Parent Eur; 1993 Oct; 22(3):18-9. PubMed ID: 12288950
[TBL] [Abstract][Full Text] [Related]
12. USA President Clinton acts to ensure reproductive health.
IPPF Open File; 1993 Feb; ():1. PubMed ID: 12286731
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone (RU 486) in the United States. What does the future hold?
Rosenfield A
N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
[TBL] [Abstract][Full Text] [Related]
14. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
[TBL] [Abstract][Full Text] [Related]
15. Early electioneering highlights party differences on key issues of choice.
Wash Memo Alan Guttmacher Inst; 1992 Jul; (12):1-2. PubMed ID: 12344813
[TBL] [Abstract][Full Text] [Related]
16. Options expand in wait for mifepristone arrival.
Contracept Technol Update; 1998 Dec; 19(12):158-60. PubMed ID: 12321807
[TBL] [Abstract][Full Text] [Related]
17. Hearing on RU486 is held as test case fails to alter FDA's "import ban".
Wash Memo Alan Guttmacher Inst; 1992 Jul; (12):2-3. PubMed ID: 12344814
[TBL] [Abstract][Full Text] [Related]
18. Life after Roe v. Wade.
Bauerlein M
Utne Read; 1992; ():17-20. PubMed ID: 12343822
[TBL] [Abstract][Full Text] [Related]
19. House vote on Hyde changes dynamic of Congressional abortion debate.
Wash Memo Alan Guttmacher Inst; 1993 Jul; (12):1-2. PubMed ID: 12286695
[TBL] [Abstract][Full Text] [Related]
20. RU-486 and the politics of reproduction.
Rosenfield A
Female Patient; 1989 Mar; 14(3):69, 73-4. PubMed ID: 12342816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]